Metraipolis › archive › dc_c046ddece1e2
Pan-cancer analysis of TRPV1: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction — Europe PMC PMID:41535811
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41535811
- DOI
- 10.1186/s12885-[numero omesso]-4
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T19:27:21.796Z
- SHA-256 of the archived text
88c719f3ab3d551101005005e937a93cafe61c601eba5af76146fd6aed276e5b- Stable URL of this page
https://metraipolis.com/documento/dc_c046ddece1e2
How to cite
Pan-cancer analysis of TRPV1: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction — Europe PMC PMID:41535811 — Europe PMC (en), https://europepmc.org/article/MED/41535811 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c046ddece1e2 (Metraipolis archive dc_c046ddece1e2, sha256 88c719f3ab3d551101005005e937a93cafe61c601eba5af76146fd6aed276e5b)
BibTeX
@misc{dcc046ddece1e2,
title = {Pan-cancer analysis of TRPV1: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction — Europe PMC PMID:41535811},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41535811},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c046ddece1e2; sha256 88c719f3ab3d551101005005e937a93cafe61c601eba5af76146fd6aed276e5b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41535811. Agents can read the archived copy with the MCP tool read_document.